1. Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituximab, gemcitabine, cisplatin, and dexamethasone). Issue 6 (12th May 2022) Authors: Naka, Ryosuke; Tada, Kohei; Kaneko, Hitomi; Nagata, Osamu; Tashima, Masaharu; Mizutani, Chisato; Imada, Kazunori Journal: Leukemia & lymphoma Issue: Volume 63:Issue 6(2022) Page Start: 1508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Primary peripheral T‐cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis. (21st February 2013) Authors: Yoshida, Noriaki; Nishikori, Momoko; Izumi, Tohru; Imaizumi, Yoshitaka; Sawayama, Yasushi; Niino, Daisuke; Tashima, Masaharu; Hoshi, Sayuri; Ohshima, Koichi; Shimoyama, Masanori; Seto, Masao; Tsukasaki, Kunihiro Journal: British journal of haematology Issue: Volume 161:Number 2(2013:Apr.) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapies. Issue 2 (17th March 2022) Authors: Naka, Ryosuke; Kaneko, Hitomi; Nagata, Osamu; Tada, Kohei; Tashima, Masaharu; Mizutani, Chisato; Imada, Kazunori Journal: EJHaem Issue: Volume 3:Issue 2(2022) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗